In Europe Preserving Patient Choice Amongst COVID-19 Vaccines
COVID-19 vaccines have made it possible for most Europeans to resume daily routines, gather with friends and family, and return to school and the workplace. Recent news reports, however, have raised concerns that patients in the EU may soon lack options amongst different vaccines.
How EU Legislation Could Threaten Clinical Trials
A new proposal from the European Commission stands to dramatically change the laws and regulations governing how new medicines are approved.
New Tools Could Boost Patient-Centered Care
Making Clinical Trials Access a Global Priority
COVID-19 Vaccination in Developing Nations
A Closer Look at the European Health Report
Every three years, the World Health Organization Regional Office for Europe releases The European Health Report, mapping health trends and marking the progress made toward achieving the region’s health goals.
A New Rare Disease Action Plan for England
An estimated 3.5 million people in the U.K. are affected by a rare disease. But, with more than 7,000 different rare diseases discovered thus far, clinicians and patients can find it difficult to keep up.
Autoimmune Patients Want Clear, Actionable Information on COVID-19
Nearly two years into the pandemic, autoimmune patients still don’t have the necessary information to make informed decisions about COVID-19 vaccination and precautions. So explains a new survey of European patients.
Healthier Prosperous Lives for All
Despite significant improvements in overall health and well-being of people across the WHO European Region, inequities persist. A new international initiative aims to change that.
HEARTS in the Americas
